Biologics License Application

Allergan Aesthetics Secures FDA Review for BOTOX Cosmetic

Irvine, California, August 4, 2026 Allergan Aesthetics, an AbbVie company, has announced that the U.S. Food and Drug Administration...

By cGxPwire Editor
August 5, 2026

Bio-Pharma

Seaport Therapeutics Reports Q2 Progress Across Neuropsychiatry Pipeline

BOSTON, Aug. 3, 2026 Seaport Therapeutics, Inc. reported its second-quarter 2026 financial results while highlighting continued progress across its...

By cGxPwire Editor
August 4, 2026

Bio-Pharma

Biocon Launches Yesafili Biosimilar to Eylea in U.S.

BENGALURU, India, and BRIDGEWATER, N.J., Aug. 3, 2026 Biocon Limited has announced the U.S. commercial launch of Yesafili™ (aflibercept-jbvf),...

By cGxPwire Editor
August 4, 2026

Bio-Pharma

Can-Fite Launches Phase 2 Piclidenoson Trial for Lowe Syndrome

RAMAT GAN, Israel, Aug. 3, 2026 Can-Fite BioPharma Ltd. has launched its first clinical development program evaluating Piclidenoson for...

By cGxPwire Editor
August 4, 2026

Bio-Pharma

Opus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial

RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2026 Opus Genetics, Inc. has completed patient enrollment in its registrational Phase 3...

By cGxPwire Editor
August 4, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

Replimune’s RP1 Gains FDA Panel Support for Advanced Melanoma

WOBURN, Mass., July 30, 2026 Replimune Group, Inc. announced a favorable outcome from the U.S. Food and Drug Administration’s...

By cGxPwire Editor
August 2, 2026

Bio-Pharma

Hansoh Pharma’s Ris-Rez Succeeds in Phase 3 Osteosarcoma Trial

SHANGHAI, July 28, 2026 Hansoh Pharmaceutical Group Co., Ltd. announced that risvutatug rezetecan (Ris-Rez/HS-20093), its proprietary B7-H3-directed antibody-drug conjugate...